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Abstract
Background and Purpose: The root extract of the African Uzara plant is used in traditional medicine as anti-diarrheal drug.
It is known to act via inhibition of intestinal motility, but malabsorptive or antisecretory mechanisms are unknown yet.
Experimental Approach: HT-29/B6 cells and human colonic biopsies were studied in Ussing experiments in vitro. Uzara was
tested on basal as well as on forskolin- or cholera toxin-induced Cl
2 secretion by measuring short-circuit current (ISC) and
tracer fluxes of
22Na
+ and
36Cl
2. Para- and transcellular resistances were determined by two-path impedance spectroscopy.
Enzymatic activity of the Na
+/K
+-ATPase and intracellular cAMP levels (ELISA) were measured.
Key Results: In HT-29/B6 cells, Uzara inhibited forskolin- as well as cholera toxin-induced ISC within 60 minutes indicating
reduced active chloride secretion. Similar results were obtained in human colonic biopsies pre-stimulated with forskolin. In
HT-29/B6, the effect of Uzara on the forskolin-induced ISC was time- and dose-dependent. Analyses of the cellular
mechanisms of this Uzara effect revealed inhibition of the Na
+/K
+-ATPase, a decrease in forskolin-induced cAMP production
and a decrease in paracellular resistance. Tracer flux experiments indicate that the dominant effect is the inhibition of the
Na
+/K
+-ATPase.
Conclusion and Implications: Uzara exerts anti-diarrheal effects via inhibition of active chloride secretion. This inhibition is
mainly due to an inhibition of the Na
+/K
+-ATPase and to a lesser extent to a decrease in intracellular cAMP responses and
paracellular resistance. The results imply that Uzara is suitable for treating acute secretory diarrhea.
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Introduction
Diarrheal diseases have a major impact on morbidity and
mortality worldwide. The subclass of secretory diarrhea is typically
induced by bacterial pathogens like enterotoxic E. coli or, in the
worst case, Vibrio cholerae. It is characterized by active secretion of
chloride and/or bicarbonate into the intestine and subsequently by
a loss of fluid [1]. Although oral rehydration therapy has reduced
mortality during the past 30 years [2], the search for antisecretory
agents is still of great importance.
Under physiological conditions, a moderate basal intestinal
secretion of electrolytes and water maintains fluid homeostasis and
provides the luminal solvent for digestive processes [1]. In
quantity, electrogenic chloride secretion is the predominant anion
secretory process. It is the result of the action of four membrane
transporters acting in concert. First, chloride uptake across the
basolateral membrane occurs by the Na
+-K
+-2Cl
2 cotransporter
(NKCC1). The Na
+/K
+-ATPase provides the driving force for this
chloride uptake by discharging sodium across the basolateral
membrane. Potassium is recycled via basolateral K
+-channels, a
process that maintains the lumen negative transepithelial potential.
Finally, the apical chloride efflux is realized via cAMP-dependent
low conductive Cl
2 channels which are present in the apical
membrane of secretory epithelial cells localized in crypt and
surface epithelium [3,4]. Water follows driven by osmotic forces
via cell membrane aquaporin channels and via paracellular water
channels formed by the tight junction protein claudin-2 [5].
To study epithelial secretory mechanisms, permanent intestinal
epithelial cell lines like HT-29/B6 cells have been successfully
used. These cells exhibit many of the features normally associated
with a chloride secretory epithelium. The cAMP-dependent Cl
2
secretion can e.g. be stimulated by forskolin or cholera toxin.
Subsequently, a lumen-negative voltage appears and a short-
circuit current (ISC) compatible with anion secretion can be
measured [6,7]. This experimental condition is ideal for analyzing
antisecretory effects of compounds such as the Uzara root extract,
using an Ussing chamber set-up for in vitro measurements.
Uzara originates from the root of the South African plant
Xysmalobium undulatum (family Asclepiadaceae) which is also known
as wild cotton, milk bush or bitterhout. As reviewed by van Wyk
[8], X. undulatum has been used internally and externally, as
decoction or as root powder, in traditional African medicine.
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cramps, and headache, but also wounds and abscesses. In
Germany, Uzara was introduced into the pharmaceutical market
in 1911. Here, it is usually used as alcoholic-aquaeus root extract
to treat acute diarrhea [9]. Uzarin, xysmalorin, and their isomers
allouzarin and alloxysmalorin have been identified as the major
Uzara compounds [9]. All four compounds are cardenolide
glycosides which exhibit similarities to those of Digitalis purpura.
Thus, at high doses Uzara has digitalis-like effects on the heart
[10]. Since pioneering in-vivo and in-vitro studies in the 1930s, the
major effect of Uzara in the treatment of diarrhea and abdominal
cramps has been ascribed to its influence on intestinal motor
function by blocking smooth muscle cell depolarization through
local stimulation of sympathetic neurons and thus diminishing
peristalsis [11–13]. Other actions of Uzara are reviewed by van
Wyk [8] and include antidepressant-like effects, possibly due to
serotonin re-uptake inhibition, fibroblast growth stimulation, and
antibacterial, antifungal, antiplasmodial and antioxidant activity.
Although Uzara has been used to treat diarrhea in Europe for
100 years, the underlying mechanisms are not fully understood.
Therefore, in the present study the effects of Uzara on
secretagogue-stimulated secretion were investigated in HT-29/
B6 cells and in human colonic biopsies. Time- and dose-
dependent inhibitory effects of Uzara on electrogenic Cl
2
secretion are presented. Analyses of tracer fluxes and para- and
transcellular resistance revealed that Uzara blocked forskolin-
induced chloride secretion through a shift of trans- and
paracellular ion movement from secretion towards absorption.
As underlying mechanisms an inhibition of the sodium potassium
pump and of cAMP synthesis could be identified.
Methods
Ethics statement
The colon biopsy protocol was approved by the local ethics
committee of the Charite ´ Berlin (EA4/098/09). Patients under-
went diagnostic colonoscopy and had given their informed consent
to taking additional samples.
Cell culture
Monolayers of the human colon carcinoma cell line HT-29/B6
[7] were grown in 25 cm
2 culture flasks containing RPMI 1640
medium (PAA laboratories, Co ¨lbe, Germany) supplemented with
10% (v/v) fetal bovine serum (Biochrom, Berlin, Germany),
0.1 mg/ml streptomycin and 100 U/ml penicillin (PAA laborato-
ries). Cells were cultured at 37uC in a humidified 5% CO2
atmosphere and splitted weekly. For experiments, cells were
seeded either in 12 mm or in 30 mm cell filter supports (PCF
3.0 mm pore size; Ø 12 mm, 8?10
5 cells/filter or Ø 30 mm, 5?10
6
cells/filter; Millipore, Eschborn, Germany) and cultured for 7–10
days to confluence.
Substance applications
Uzara (UzaraH Solution N, Stada, Bad Vilbel, Germany) was
purchased as dry extract with a concentration of 40 mg/ml
glycosides in a alcoholic solution (43%). Forskolin and nystatin
(Sigma-Aldrich, Steinbach, Germany) were dissolved in dimethyl-
sulfoxid (DMSO). Ouabain (Merck, Darmstadt, Germany),
fluorescein and cholera toxin (Sigma-Aldrich) were dissolved in
water. Stock solutions were further dissolved with bathing medium
to achieve final DMSO or ethanol concentration below 0.1%. All
other chemicals, unless otherwise noted, were purchased from
Sigma-Aldrich.
Electrophysiology
For electrophysiological measurements, confluent cell layers on
filter supports (Millicell PCF 3.0 mm pore size, Ø 12 mm, effective
area 0.6 cm
2) were directly mounted in conventional Ussing
chambers to measure the transepithelial resistance (R
t or TER,
V?cm
2; modified method described by Kreusel et al., 1991).
Standard bathing solution contained in mM: 140 Na
+, 123.8 Cl
2,
5.4 K
+, 1.2 Ca
2+, 1.2 Mg
2+, 2.4 HPO4
22, 0.6 H2PO
42,2 1
HCO3
2, 10 D-(+)-glucose. Solution was constantly equilibrated
with 95% O2 and 5% CO2, to keep a pH value of 7.4 at 37uC. In
HCO3
2 free solutions, NaHCO3 was replaced by equimolar
concentrations of NaCl and 10 mM HEPES was added. pH was
adjusted to 7.4 with NaOH and the solution was constantly
equilibrated with 100% O2. Baseline values were measured prior
to each experiment which includes the resistance of the bathing
solution and the empty filter support.
Experiments were performed under short-circuit conditions. For
uni-directional ion flux measurements 2.4 kBq/ml
22Na
+ and
9.2 kBq/ml
36Cl
2 (NEN Life Science Products, USA) were used
and added either to the mucosal or serosal side (ms or sm
direction, respectively). Three 20 min flux periods were analyzed.
A 100 ml sample was taken from the application side upon
initiation and mixed with 900 ml bathing solution. Samples (1 ml)
were collected from the receiving side. Volumes were replaced
with fresh solution. Radioactivity of
22Na
+ was counted in a 1480
Wizard TM3 counter (Wallac, Rodgau-Ju ¨gesheim, Germany).
Subsequently the samples were mixed with 4 ml Ultima Gold high
flash-point liquid scintillation cocktail (Packard Bioscience,
Groningen, Netherlands) and counted again for
36Cl
2 in a Tri-
Carb 2100TR Liquid Scintillation counter (Perkin Elmer, Boston,
USA).
To asses cell viability in the absence and presence of Uzara over
a period of 48 hours, transepithelial resistance measurements were
carried out on filter supports in Petri dishes, using chop-stick type
electrodes (STX-2, World Precision Instruments, Berlin, Ger-
many) as previously described [14].
Biopsy specimens from distal colon (30 cm ab ano) were obtained
endoscopically from three control patients (2 male and 1 female;
range 39–66 years) undergoing colonoscopy for tumor exclusion
who did not show inflammation, either macroscopically or
microscopically. Tissues were transported to the laboratory on
ice in oxygenated bath solution. Specimens were spread out under
a dissection microscope and a plastic ring with an inner diameter
of 2.5 mm was glued to the serosal side of the biopsy using
histoacryl tissue glue (B. Braun, Melsungen, Germany). Subse-
quently, this ring was placed in a micro-container tightened with
silicon rubber seals and mounted in specialized Ussing-type
chambers as previously described [15,16]. The time between
taking the biopsies and mounting the tissues into Ussing chambers
(0.049 cm
2) was approximately 10–15 minutes. To avoid bacterial
growth, piperacillin (50 mg/l) and imipenem (10 mg/l) were
added to the bath solutions. Both antibiotics had no effect on ISC
at the concentration used.
cAMP enzyme-linked immunoabsorbent assay (EIA)
Cell cultures growing on filter supports were incubated serosally
with 50 mg/ml Uzara 30 minutes prior to serosal addition of
10 mM forskolin. Forskolin and Uzara alone were also tested and
compared with untreated monolayers. 1 hour after forskolin
addition, cells were washed twice with phosphate-buffered saline
(PBS, PAA laboratories) and incubated with 0.1 M HCl for 20
minutes. Lysed cells were scraped off and centrifuged at 1000 6g
for 10 minutes. The protein content of the supernatant was
determined by employing BCA protein assay reagents (Pierce,
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Germany). Samples were dissolved and applied in the cAMP EIA
Kit according to the manufacturer’s instruction (Cayman
Chemicals, IBL, Hamburg, Germany). The reaction was mea-
sured at a wavelength of 420 nm using a Spectra Max 340 PC
(Molecular Devices, Union City, California, USA).
Na
+/K
+-ATPase activity
Determination of Na
+/K
+-ATPase activity in membrane
fractions of HT-29/B6 cells was performed with minor modifica-
tion according to Sadrzadeh et al. [17]. After washing with PBS,
cells were scraped from the permeable supports or culture flasks
and homogenized in imidazole buffer (20 mM, pH 7.4) containing
EDTA (0.5 mM). Samples were homogenized by shearing
repeatedly through a hypodermic needle with a diameter of
0.9 mm and then by another one measuring 0.45 mm (B. Braun).
The membrane fraction was obtained by 5 min centrifugation at
200 g (4uC) and a subsequent centrifugation of the resulting
supernatant at 43,0006g for 30 minutes (4uC). Pellets were re-
suspended in histidine-imidazole buffer (40:40 mM, pH 7.1). The
protein content was determined by the BCA protein assay
reagents.
Assays were performed in microtiter plates measuring the
formation of inorganic phophate (Pi). Pi released from ATP by the
ATPase activity was quantified from a color reaction by means of
the Spectra Max 340 PC at a wavelength of 810 nm using a Pi
concentration standard. The activity of the Na
+/K
+-ATPase (in
nmol/(min?mg)) was calculated from the difference of the entire
ATPase activity and the blocking properties of 2.5 mM ouabain, a
specific inhibitor of the Na
+/K
+-ATPase (Merck). The effect of
Uzara on the Na
+/K
+-ATPase was measured either by incubation
of the cell monolayer with Uzara or by incubation of the
membrane fractions directly with Uzara in the incubation
medium. Each sample was determined in triplicates.
Two-path impedance spectroscopy
Confluent cell layers on filter supports were directly mounted in
chambers specially designed for impedance measurements. Para-
cellular (R
para) and transcellular (R
trans) were measured by two-
path impedance spectroscopy as described in detail by Krug et al.
[18]. Both hemichambers were filled with 10 ml circulating bath
solution (composition equal to the solution used in the conven-
tional Ussing chamber). A programmable frequency response
analyzer (402, Beran Instruments, Devon, UK) in combination
with an electrochemical interface (1286, Solartron Schlumberger,
Farnborough, UK) was employed for application of sinusoidal
currents in frequencies from 1 Hz to 65 kHz. R
trans and R
para are
calculated from impedance spectra and fluxes of the paracellular
marker, fluorescein (332 Da), which were obtained before and
after chelating extracellular Ca
2+ with EGTA.
Statistical analysis
Data are expressed as means 6 standard error of the mean
(s.e.m.). Statistical analysis comparing two groups was performed
by using Student’s t-test. ANOVA with Bonferoni-Holm adjust-
ment was used in cases of multiple comparisons. P,0.05 was
considered significant.
Results
Effect of Uzara on the forskolin-induced increase in ISC in
HT-29/B6 cells
Monolayers of HT-29/B6 cells were mounted into Ussing
chambers. Under resting conditions ISC stabilized on a level of
17.161.6 mA/cm
2 (n=5). Uzara (50 mg/ml) added to the
basolateral compartment slightly reduced ISC to 7.660.3 mA/
cm
2 (n=8) after 80 minutes of incubation (P,0.001). When
forskolin (10 mM, basolaterally) was applied, ISC rapidly increased
to 59.964.0 mA/cm
2 equivalent to a net transport of monovalent
ions of 2.2360.15 mmol/(h?cm
2) (n=6) and remained on this level
for at least 80 min (Fig. 1A, P,0.001).
Two different experimental designs were used to characterize the
anti-diarrheal effect of Uzara: (1) basolateral pre-incubation with
Uzara(50 mg/ml)andsubsequent additionofa secretagogueand(2)
basolateral addition of Uzara after pre-stimulation of electrogenic
transport by 10 mM forskolin for 30 minutes. Both experimental
protocols yielded direct evidence for an antisecretory effect of Uzara
(Fig. 1A and B). In contrast to basolateral addition, apical
application of 50 or 100 mg/ml Uzara had no inhibitory effect on
a forskolin-mediated ISC increase (data not shown). Thus, the
efficacy of Uzara was clearly restricted to basolateral application.
In addition, different Uzara concentrations (from 2 to 150 mg/
ml) were tested for blocking the forskolin-stimulated ISC response.
Here, Uzara was applied to the basolateral compartment 30
minutes after addition of forskolin (Fig. 1C). The inhibitory effect
of Uzara on the forskolin-induced ISC increase was concentration-
dependent with an IC50 of 17 mg/ml (estimated from a linear
regression of values between 2 and 100 mg/ml in a Hill plot, n=5-
7, R
2=0.93) and a Hill coefficient of 1.45.
All further experiments were carried out at Uzara concentra-
tions of 50 mg/ml. To asses cell viability at this concentration,
transepithelial resistance was measured over a time period of 48 h.
As shown in Fig. 1D, transepithelial resistance between control cell
layers (treated with ethanol only, final concentration 0.05%) and
cell layers treated with Uzara did not differ significanly during the
first 8 h after application. 24 h after application, Uzara-treated
cell layers exhibited a reduced resistance, which, however,
recovered over the following 24 h, so that 48 h after application
there were again no significant difference between contol- and
Uzara-treated cell layers. Therefore, even an exposure for 48 h to
50 mg/ml uzara did not affect cell viability. During all further
experiments exposure to Uzara never exceeded 3 h.
Effect of Uzara on the forskolin-stimulated cAMP level in
HT-29/B6 cells
Forskolin increases the intracellular concentration of cAMP by
activating the adenylate cyclase. Subsequently, this second
messenger activates apical Cl
2 channels required for the Cl
2
efflux across the apical enterocyte membrane.
For testing the effect of Uzara on intracellular cAMP levels,
cellular cAMP content was measured under the influence of
forskolin and Uzara. HT-29/B6 cells growing on filter supports
were pre-incubated for 30 minutes with Uzara before forskolin was
added. 60 minutes after addition of forskolin cells were lysed for
measuring the intracellular cAMP content. Forskolin increased the
cAMP content up to 130-fold when compared to control and Uzara
partially blocked this cAMPincrease byalmost70% (Fig. 2, n=5-6).
Effect of Uzara on the activity of the Na
+/K
+-ATPase in
HT-29/B6 cells
The Na
+/K
+-ATPase participates in the process of electrogenic
chloride secretion. For analyzing the Uzara effect on the activity of
the Na
+/K
+-pump, the activity was measured in two types of
experiments. First, HT-29/B6 cells grown on culture plate inserts
were incubated basolaterally with 50 mg/ml Uzara for 1.5 hours.
Subsequently, extracts of membrane fraction were prepared and
tested (n=8). Secondly, Uzara was added directly to the
Anti-Diarrheal Mechanism of Uzara
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procedures clearly revealed an inhibitory activity of Uzara on
the Na
+/K
+-ATPase. The inhibitory efficacy was higher when
Uzara was directly applied to the assay than when added to the
incubation medium of the cell monolayers (6563% versus 3766%
inhibition of control values, respectively; Fig. 3).
Effects of Uzara and ouabain on carbachol- and
nystatin-induced transport in HT-29/B6 cells
To further elucidate the mechanisms behind the effects of Uzara
(50 mg/ml), ouabain (100 mM), carbachol (100 mM) and nystatin
(15 mg/ml), respectively, were applied to HT-29/B6 cell layers.
Carbachol induces an increase in the intracellular Ca
2+ concen-
tration and thereby activates basolateral, Ca
2+-sensitive K
+
channels and probably to a lesser extent also apical Ca
2+-sensitive
Cl
2 channels. In the absence of a concomittant activation of
apical, cAMP-sensitive Cl
2 channels, this causes a brief, transient
Cl
2 secretion of about 2 min duration and a maximum amplitude
of 34.464.5 mA/cm
2. If cell layers were preincubated with Uzara
or ouabain 30 min prior to carbachol application this amplitude
was reduced to 21.363.5 and 12.361.4 mm A/cm
2, respectively
(n=6, Fig. 4A).
In contrast, apical application of nystatin, which is known to
perforate cell membranes, increased ISC reaching a plateau of
about 54 mA/cm
2. Addition of Uzara or ouabain after 30 min
inhibited the nystatin-mediated ISC rise. Ouabain was more
effective than Uzara, in accordance with its stronger inhibitory
effect on the Na
+/K
+-ATPase (Fig. 4B).
Effect of Uzara and forskolin on Na
+ and Cl
2 fluxes in
HT-29/B6 cells
Results of Na
+ and Cl
2 flux measurements are shown in
Table 1. The secretagogue forskolin (10 mM) increased both, JCl
ms
(the mucosal-to-serosal Cl
2 flux) and JCl
sm (the serosal-to-mucosal
Figure 1. Inhibitory effect of Uzara on the forskolin-induced ISC rise in HT-29/B6 cells. ISC was measured on HT-29/B6 monolayers
mounted in Ussing chambers. In A and B, Uzara (50 mg/ml) was added on the basolateral side either 30 minutes prior (A) or 30 minutes after (B)
basolateral addition of 10 mM forskolin. In C, different Uzara concentrations were applied basolaterally 30 minutes after forskolin stimulation. The
percentage of the inhibitory activity of Uzara to the forskolin-induced ISC rise was calculated after an incubation time of 1 hour. An IC50 of 17 mg/ml
and a Hill coefficient of 1.45 were determined from a Hill plot diagram and used to calculate the continuous line. All values are expressed as mean 6
s.e.m. (n=5-7). D: Transepithelial resistance measurements over 48 hours after application of either ethanol (control: final concentration 0.05%)o r
50 mg/ml Uzara (final ethanol concentration 0.054%). With the exception of the resistances 24 hours after the application of uzara, none of the
resistance values in the presence of uzara differed significantly from the corresponding control value. (means 6 s.e.m. n=12).
doi:10.1371/journal.pone.0018107.g001
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- flux) but JCl
sm to a greater extent, as a result of which net Cl
-
flux was markedly increased in secretory direction.
If Uzara was applied 30 minutes prior to forskolin addition,
both Cl
2 fluxes were increased. However, JCl
ms was almost
doubled, while JCl
sm was only slightly affected. Thus, net flux
analysis revealed that Uzara stimulated the Cl
2 absorption and
modulated the secretory Cl
2 response to forskolin resulting in net
Cl
2 transport values of untreated monolayers. Uzara alone had no
effects on the Cl
2 flux.
In contrast to Cl
2 fluxes, Na
+ fluxes were not affected by
forskolin and/or Uzara. Residual flux (usually assumed to reflect
bicarbonate secretion), which showed a tendency to be enhanced
by forskolin, was not reversed by Uzara. Finally, the forskolin-
induced reduction in R
t was not altered by Uzara co-incubation.
Effect of DIDS on the forskolin-induced ISC in the
presence or absence of Uzara
DIDS (0.1 mM) affected forskolin-induced ISC only when
applied to the basolateral side. The response consisted of a
transient increase in ISC followed by a decline below the plateau
ISC value prior to the addition of DIDS. These changes were not
related to transport of bicarbonate, as they were still present in
bicarbonate-free solutions equilibrated with 100% O2. Preincu-
bation with Uzara did not affect the transient increase in ISC but
Figure 2. Inhibitory effect of Uzara on the forskolin-induced
accumulation of intracellular cAMP in HT-29/B6 cells. HT-29/B6
monolayers were incubated basolaterally with 50 mg/ml Uzara 30 min
prior to basolateral forskolin (10 mM) addition. After an incubation time
of 1 h, cell lysates were prepared and the content of cAMP was assayed
with EIA. The data shows that forskolin increased the intracellular cAMP
level, whereas Uzara partly blocked this rise in cAMP. Values are
expressed as mean 6 s.e.m. (n=5-6). Asterisks indicate difference
versus control: ***P,0.001.
doi:10.1371/journal.pone.0018107.g002
Figure 3. Inhibitory effect of Uzara on the Na
+/K
+-ATPase
enzymatic activity in membrane preparations from HT-29/B6
cells. In cell culture experiments, monolayers were treated with
50 mm g/ml Uzara for 90 min. Then, cells were homogenized and a
crude membrane fraction was prepared. Herein, the Na
+/K
+-ATPase
activity was measured (n=5). In a further set of experiments, membrane
fractions of untreated HT-29/B6 cell monolayers were prepared and
subsequently treated with 50 mg/ml Uzara which was added for 1 h to
the enzyme activity assay (n=8). Both conditions revealed a direct
inhibitory activity on the ion pump. Values are expressed as percentage
of control activity. Basal activity of the Na
+/K
+-ATPase was between 36
and 73 nmol Pi/(min?mg protein). Data are expressed as mean 6 s.e.m.
Asterisks indicate difference versus control: ***P,0.001.
doi:10.1371/journal.pone.0018107.g003
Figure 4. Inhibitory effect of Uzara and ouabain on the
nystatin-induced ISC rise in HT-29/B6 cells. The effects of Uzara
and ouabain, a specific inhibitor of the Na
+/K
+-ATPase, were analyzed
on the rise in ISC induced by nystatin. Nystatin (15 mg/ml) which
perforates cell membranes was applied to the mucosal compartment
30 min prior to basolateral addition of 50 mg/ml Uzara or 100 mM
ouabain. ISC was measured in HT-29/B6 cell monolayers mounted in
Ussing chambers. The nystatin-induced rise in ISC was diminished by
Uzara as well as by ouabain. Data are expressed as mean 6 s.e.m.
(n=4).
doi:10.1371/journal.pone.0018107.g004
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accelerated decline was also observed, if ouabain was used instead
of Uzara, but was not observed if Uzara was added after the
application of forskolin and DIDS (Fig. 5).
Effect of Uzara or ouabain with or without forskolin on
the para- and transcellular resistance in HT-29/B6 cells
The para- and transcellular resistance (R
para and R
trans) were
measured by two-path impedance spectroscopy, to decide whether
the increase in JCl
ms flux in the Uzara-forskolin group compared to
forskolin alone was due to shifts in the paracellular or in the
transcellular pathway. Results are shown in Fig. 6.
Uzara or ouabain alone had no influence on R
para and R
trans.
Forskolin mediated a reduction in R
trans of over 70% which was
paralleled by Cl
2 secretion and a R
t decrease. R
para remained
unchanged by forskolin. The co-incubation of Uzara or ouabain
with forskolin did not attenuate the forskolin-induced R
trans
reduction. In contrast, R
para was significantly reduced by about
40% in the Uzara-forkolin group compared to forskolin. A slight
R
para reduction observed in the presence of ouabain was not
statistically significant.
Effect of Uzara on cholera toxin-stimulated ISC rise in
HT-29/B6 cells
Effects of Uzara on the cholera toxin-induced ISC rise was tested.
Similar to forskolin, cholera toxin acts as an activator of the
adenylate cyclase resulting in an increase of ISC and Cl
2 secretion.
Mucosaladdition of 1 mg/ml cholera toxin increased ISC starting 40
minutes after addition and reaching a maximumafteran incubation
time of 150 minutes. At this time point, 50 mg/ml Uzara were
applied basolaterally to the monolayer. As in the forskolin-induced
design, Uzara also inhibited the cholera toxin-stimulated ISC
response reaching initial values again after 60 minutes (Fig. 7).
Effect of Uzara on forskolin-stimulated ISC rise in human
colonic tissues
To test the Uzara effects not only on permanent intestinal cell
cultures butalsoon native intestine, human colonic tissue specimens
were investigated in the Ussing chamber. Tissues were pre-
incubated basolaterally with forskolin, in order to induce an ISC
response. Then, Uzara was added basolaterally. As in HT-29/B6
cells, forskolin increased ISC within minutes reaching a maximum
after 40 minutes incubation. Uzara was applied 20 minutes after
forskolin addition. Uzara diminished the forskolin-stimulated DISC
reaching initial values after about 60 minutes (Fig. 8).
Discussion
The plant Uzara has been used for a long time in traditional
medicine to treat diarrheal disorders, but the mode of action is not
fully known. In Germany, Uzara (Stada, Bad Vilbel, Germany) is
frequently used as over-the-counter preparation of the Uzara root,
containing 40 mg glycosides/ml. In our present study, the antisecre-
Table 1. Influence of Uzara and forskolin on Na
+ and Cl
2 fluxes in HT-29/B6 cells.
JNa
ms JNa
sm JNa
net JCl
ms JCl
sm JCl
net Jres ISC R
t
control (n=7) 0.6760.09 0.6260.06 0.0460.08 0.9460.13 1.3160.06 20.3760.10 0.1160.09 0.5260.05 702653
Uzara (n=5) 0.7260.23 0.5060.03 0.2260.22 0.9060.22 1.0360.06 20.1360.17 20.0860.19 0.2860.02* 735665
forskolin (n=7) 0.6660.06 0.8160.09 20.16 60.07 2.4860.09# 4.3560.16# 21.876 0.19# 0.8360.25 2.5460.12# 306610#
Uzara+forskolin (n=6) 0.8960.08 1.0060.19 20.1160.19 4.7060.231 5.1160.131 20.4160.241 0.4860.29 0.7860.041 316616
ouabain+forskolin (n=2) 3.6060.07 4.2760.15
JNa and JCl, unidirectional Na
+ and Cl
2 fluxes;
ms, from mucosal to serosal side;
sm, from serosal to mucosal side; all fluxes are expressed as mmol?h
21?cm
22.
J
net, net fluxes (J
ms-J
sm).
Jres, residual fluxes (ISC-JNa
net+JCl
net, usually assumed to reflect bicarbonate secretion).
ISC, short-circuit current (for comparison expressed in mmol?h
21?cm
22 of monovalent cations).
R
t, transepithelial resistance (V?cm
2).
All values represent means 6 SEM.
*, P versus control ,0.05.
#, P versus control ,0.001.
1, P versus forskolin alone ,0.001.
doi:10.1371/journal.pone.0018107.t001
Figure 5. Effects of DIDS on forskolin-induced ISC in the
absence and presence of Uzara or ouabain. Experiment in HCO3
2
free solutions equilibrated with 100% O2. Application of 10 mM forskolin
induced an ISC that was reduced in the presence of Uzara (50 mg/ml)
and ouabain (100 mM). Under all three conditions, application of DIDS
(100 mm M) caused a pronounced transient increase in ISC, presumably
due to an increase in intracellular Ca
2+. Similar to the carbachol-induced
ISC, the current amplitude was reduced in the presence of Uzara and
ouabain. ISC in the presence of DIDS then rapidly decreased, if
preparations were pre-incubated with Uzara (light blue) or ouabain
(pink). This effect is attributed to additional Na
+ loading of the cells.
Application of DIDS before the addition of Uzara (blue) had no such
accelerating effect.
doi:10.1371/journal.pone.0018107.g005
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monolayers as well as native colonic tissue obtained during endoscopy.
Two different signaling pathways are involved in human colonic
Cl
2 secretion, a Ca
2+-mediated and a cAMP-mediated secretory
component [19,20]. In both cases, Cl
2 secretion is due to an
activation of apical Cl
2 channels and basolateral K
+ channels. Ion
movement is maintained by two basolateral ion transporters,
NKCC1 and Na
+/K
+-ATPase [3,4,21].
To get more insight into the mechanisms of the antisecretory
effect of Uzara, active intestinal secretion was stimulated with the
secretagogues forskolin, cholera toxin and carbachol. Both,
forskolin and cholera toxin lead to an activation of the andenylate
cyclase and thus to an increase of intracellular cAMP. This induces
a long-lasting electrogenic Cl
2 secretion [22,23] through co-
activation of cAMP-sensitive Cl
2 channels (CFTR; [3,4]) and K
+
channels (KCNQ1/KCNE3, [24]) in isolated intestinal prepara-
tions in vitro as well as in cultured cells of colonic origin. In
contrast, carbachol, an agonist of muscarinic acetylcholine
receptors, causes an increase in intracellular Ca
2+ concentration
and thus activates basolateral Ca
2+-dependent K
+ channels
(KCNN4, [4]). At low cAMP levels, this only causes small
increases in ISC, probably due to a scarcity in Ca
2+-dependent Cl
2
channels in the apical membrane. Increase in intracellular Ca
2+
can, however, potentiate cAMP-induced Cl
2 secretion [3,25].
DIDS is commonly used as inhibitor of Cl
2 channels or HCO3
2-
dependent carriers. However, in epithelial cells it has previously
beenobserved thatDIDS, similarlytocarbachol, maystimulateCl
2
secretion by releasing Ca
2+ from intracellular stores [26,27].
In the present study, the Cl
2 secretion induced by forskolin was
measured as ISC response in HT-29/B6. ISC increase was apparent
Figure 6. Effects of Uzara, ouabain and forskolin on R
para and
R
trans in HT-29/B6 cells. The influence of Uzara and ouabain on R
para
and R
trans with and without forskolin was determined by two-path
impedance spectroscopy in HT-29/B6 cell monolayers mounted in
Ussing chambers. Forskolin reduced R
trans, whereas R
para remained
unaltered. The co-incubation of Uzara with forskolin caused no change
of R
trans compared to forskolin alone, whereas R
para was clearly reduced
in the co-incubation group. Similarly, compared to forskolin alone,
ouabain together with forskolin had no effect on R
trans. The slight
reduction of R
para observed under these conditions did not reach
significance. Data are expressed as mean 6 s.e.m. (n=5-6). Untreated
control values set as 1. Asterisk indicates a difference compared to
forskolin: **P,0 . 0 1 .H a s hk e y sm e a nn os t a t i s t i c a ls i g n i f i c a n c e
compared to forskolin alone.
doi:10.1371/journal.pone.0018107.g006
Figure 7. Inhibitory effect of Uzara on the cholera toxin-
mediated ISC rise in HT-29/B6 cells. ISC was measured in HT-29/B6
cell monolayers mounted in Ussing chambers. Uzara (50 mg/ml) was
applied on the basolateral side 150 min after mucosal addition of 1 mg/
ml cholera toxin. The data show that Uzara diminished also the cholera
toxin-induced rise in ISC. Values are expressed as mean 6 s.e.m. (n=6).
doi:10.1371/journal.pone.0018107.g007
Figure 8. Inhibitory effect of Uzara on the forskolin-mediated
ISC rise in human colonbiopsy specimens. Delta ISC (DISC) was
determined in human colon mounted in Ussing chambers. Forskolin
(10 mM) was added to the basolateral side 15 min prior to basolateral
addition of 50 mg/ml Uzara. Also in colonic biopsies, Uzara diminished
the forskolin-induced rise in ISC. Data are expressed as mean 6 s.e.m.
(n=5).
doi:10.1371/journal.pone.0018107.g008
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toxinhada delayofabout40minutesandreachedmaximumvalues
only after 2.5 hours. This delay in cholera toxin action is due to the
complex chain of processes necessary to finally activate the
adenylate cyclase and stimulate anion secretion [28]. The plant
extract Uzara effectively diminished both, the secretory response to
forskolin and to cholera toxin. Moreover, the inhibitory effect of
Uzara could also be confirmed in human colon biopsies.
Uzara was found to have three major effects: a partial inhibition
of the Na
+/K
+-ATPase, a partial inhibition of the forskolin-
induced cAMP increase (inhibition of the adenylate cyclase and/or
activation of the phosphodiesterase) and, in the presence of
forskolin, a reduction in paracellular resistance. Of these, only
inhibition of the Na
+/K
+-ATPase is shared with ouabain.
Although not investigated in the present study, there are several
reports that ouabain rather activates than inhibits the adenylate
cyclase ([29], and references therein), and, as shown in Fig. 6,
paracellular resistance is not affected by ouabain. Despite these
differences, Uzara-induced inhibition of the Na
+/K
+-ATPase
appeared to be the dominant effect in the present study, as the
inhibitory effect of Uzara compared to ouabain was independent
of the mode of Cl
2 secretion stimulation, i.e. with (forskolin) and
without (carbachol, nystatin) concomittant increase in intracellular
cAMP levels. Furthermore, during submaximal forskolin stimula-
tion, the inhibitory effect of Uzara relative to ouabain was not
increased (data not shown), as would be expected, if reduced
cAMP responses played a crucial role.
The increase in uni-directional Cl
2 fluxes during the combined
application of forskolin together with Uzara (and ouabain,
respectively) is consistent with an increase in intracellular Na
+
concentrations due to the inhibition of the Na
+/K
+-ATPase. Under
these conditions, NKCC1 is close to its thermodynamic equilibrium
and will therefore move ions across the basolateral membrane in
both directions. Whereas Na
+ and K
+ permeabilities of the apical
membrane in the presence of forskolin remain low, Cl
2 can pass
both membranes. Under conditions of NKCC1 equilibrium, this
movement can therefore occur in both directions at equal rates.
This interpretation is further supported by the results obtained
during the application of DIDS (Fig. 5). Basolateral application of
DIDS in the presence of forskolin caused an additional, transient
Cl
2 secretion that has been attributed to an intracellular Ca
2+
release [26,27] and that is also driven by NKCC1. During an
inhibition of the Na
+/K
+-ATPase (in the presence of Uzara or
ouabain) this accelerates loading ofthecells with Na
+, causing ISC to
rapidly approach baseline values again. Reversal of the experiment,
i.e. application of Uzara after the application of DIDS, does not
cause this rapid decrease in ISC, as DIDS-induced Na
+ loading of
the cell is prevented by the action of the Na
+/K
+-ATPase (Fig. 5).
Interestingly, control data from a small group point to a higher
effect of Uzara than of ouabain on uni-directional Cl
2 fluxes
(respective ms- and sm-fluxes in mmol/(h?cm
2): Uzara, 4.7060.23
and 5.1160.13, n = 6 versus ouabain 3.6060.07 and 4.2760.15,
n = 2). This is most likely due to the Uzara-induced decrease in
R
para that short-circuits the epithelial layer and thus prevents the
maintenance of osmotically active gradients across the epithelium.
This may further contribute to the anti-diarrheal effect of Uzara.
To date, several reports on extra-intestinal cells point to an
inhibitory potential of Uzara glycosides on the Na
+/K
+-ATPase
[10,30,31]. Uzara ingredients like uzarigenin and uzarin were
shown to bind to the Na
+/K
+-ATPase and inhibit its activity.
However, serum concentrations reached during treatment with
Uzara remain below 10 ng/ml [32] and thus well below Kd values
reported for the major Uzara compound, uzarin (,700 Da), in the
order of 1 mM (pig kidney ATPase[30]), 1.5 mM and 4.3 mM
(cattle and guinea pig heart muscle ATPase, respectively [10]).
This may explain, why Uzara administration in healthy subjects
does not affect cardiovascular parameters evaluated by electro-
cardiography and impedance cardiography [33]. In contrast, at
the site of Uzara absorption as result of an inflamed or attacked
intestinal mucosa, local concentrations may well increase suffi-
ciently to exert anti-secretory effects.
In conclusion, the traditional remedy Uzara exerts its anti-
diarrheal effects not only through the previously reported inhibition
of intestinal motility [11–13] but, in addition, through effects on the
intestinal epithelium via inhibition of active secretion. This is caused
by a partial inhibition of the Na
+/K
+-ATPase, by a reduction in
intracellular cAMP responses (either through partial inhibition of the
adenylate cyclase or by an activation of the phosphodiesterase), and
by a decrease in paracellular resistance. It is inferred, that Uzara is
suitable for treating secretory diarrhea caused e.g. by bacterial toxins
as well as motility-related diarrhea, but may not be effective against
chronicmalabsorptivediarrheawithtwoexceptions.First,chologenic
diarrhea is driven by deconjugated bile acid-induced anion secretion
in the colon. Second, lipid malabsorption during steatorrhea leads to
b- h y d r o x y l a t i o no ff a t t ya c i d si nt h ec o l o nw h i c hc a nt r i g g e ra c t i v e
anion secretion. It is reasonable to assume that these two
malabsorptive types of diarrhea are uzara-sensitive as well, although
direct experimental evidence for both conditions is lacking.
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